McKesson Earnings
NYSE: MCKHealth CareOther PharmaceuticalsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
After market close
Fiscal period
Sep/2026
EPS estimate
$10.72
McKesson earnings summary
McKesson is scheduled to report Sep/2026 earnings on Nov 4, 2026 after the market closes, with analysts expecting EPS of $10.72. In its most recent report on Aug 5, 2026 (Q1 2027), MCK posted EPS of $5.15. Revenue for the quarter was $105.38 billion.
Quarterly EPS is down 17.6% from the same quarter a year earlier. Across the last 16 reports, MCK shares moved an average of 2.4% (in either direction) in the first trading session after results, rising 10 times and falling 6 times.
Summary generated from market data by MetaCap's automated system. Methodology
MCK earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 5, 2026 | — | $5.15 | — | -0.1% |
| May 8, 2026 | — | $13.62 | — | +3.3% |
| Feb 4, 2026 | — | $9.59 | — | -1.5% |
| Nov 6, 2025 | — | $8.92 | — | -1.2% |
| Aug 6, 2025 | — | $6.25 | — | +0.7% |
| May 9, 2025 | — | $9.90 | — | +4.4% |
| Feb 6, 2025 | — | $6.95 | — | -0.3% |
| Nov 7, 2024 | — | $1.87 | — | -1.1% |
| Aug 7, 2024 | — | $7.00 | — | +1.2% |
| May 8, 2024 | — | $6.03 | — | +0.8% |
| Feb 8, 2024 | — | $4.42 | — | +1.9% |
| Nov 2, 2023 | — | $4.92 | — | +3.7% |
| Aug 2, 2023 | — | $7.02 | — | +4.3% |
| May 9, 2023 | — | $5.69 | — | +2.0% |
| Feb 2, 2023 | — | $7.66 | — | +1.5% |
| Nov 2, 2022 | — | $6.42 | — | -10.2% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.